125 related articles for article (PubMed ID: 37706534)
21.
Cancer Discov; 2018 Sep; 8(9):1055. PubMed ID: 30006379
[TBL] [Abstract][Full Text] [Related]
22. Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy.
Wu W; Yu S; Yu X
Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188842. PubMed ID: 36460141
[TBL] [Abstract][Full Text] [Related]
23. Role and therapeutic potential of CDK12 in human cancers.
Chilà R; Guffanti F; Damia G
Cancer Treat Rev; 2016 Nov; 50():83-88. PubMed ID: 27662623
[TBL] [Abstract][Full Text] [Related]
24. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
[TBL] [Abstract][Full Text] [Related]
25. Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications.
Popova T; Manié E; Boeva V; Battistella A; Goundiam O; Smith NK; Mueller CR; Raynal V; Mariani O; Sastre-Garau X; Stern MH
Cancer Res; 2016 Apr; 76(7):1882-91. PubMed ID: 26787835
[TBL] [Abstract][Full Text] [Related]
26. [Function of CDK12 in Tumor initiation and progression and its clinical consequences].
Vrábel D; Svoboda M; Navrátil J; Kohoutek J
Klin Onkol; 2014; 27(5):340-6. PubMed ID: 25312711
[TBL] [Abstract][Full Text] [Related]
27. Lack of evidence for CDK12 as an ovarian cancer predisposing gene.
Eeckhoutte A; Saint-Ghislain M; Reverdy M; Raynal V; Baulande S; Bataillon G; Golmard L; Stoppa-Lyonnet D; Popova T; Houdayer C; Manié E; Stern MH
Fam Cancer; 2020 Jul; 19(3):203-209. PubMed ID: 32172432
[TBL] [Abstract][Full Text] [Related]
28. Analysis of CDK12 alterations in a pan-cancer database.
Pan E; Cabal A; Javier-DesLoges J; Patel D; Panian J; Lee S; Shaya J; Nonato T; Xu X; Stewart T; Rose B; Shabaik A; Cohen E; Kurzrock R; Tamayo P; McKay RR
Cancer Med; 2022 Feb; 11(3):753-763. PubMed ID: 34898046
[TBL] [Abstract][Full Text] [Related]
29. CDK12: an emerging therapeutic target for cancer.
Lui GYL; Grandori C; Kemp CJ
J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
[TBL] [Abstract][Full Text] [Related]
30. Proteogenomics connects somatic mutations to signalling in breast cancer.
Mertins P; Mani DR; Ruggles KV; Gillette MA; Clauser KR; Wang P; Wang X; Qiao JW; Cao S; Petralia F; Kawaler E; Mundt F; Krug K; Tu Z; Lei JT; Gatza ML; Wilkerson M; Perou CM; Yellapantula V; Huang KL; Lin C; McLellan MD; Yan P; Davies SR; Townsend RR; Skates SJ; Wang J; Zhang B; Kinsinger CR; Mesri M; Rodriguez H; Ding L; Paulovich AG; Fenyö D; Ellis MJ; Carr SA;
Nature; 2016 Jun; 534(7605):55-62. PubMed ID: 27251275
[TBL] [Abstract][Full Text] [Related]
31. Gene expression regulation by CDK12: a versatile kinase in cancer with functions beyond CTD phosphorylation.
Choi SH; Kim S; Jones KA
Exp Mol Med; 2020 May; 52(5):762-771. PubMed ID: 32451425
[TBL] [Abstract][Full Text] [Related]
32. Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination.
Fan L; Fei X; Zhu Y; Chi C; Pan J; Sha J; Xin Z; Gong Y; Du X; Wang Y; Dong B; Xue W
J Urol; 2021 Sep; 206(3):630-637. PubMed ID: 33904759
[TBL] [Abstract][Full Text] [Related]
33. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
Koga Y; Song H; Chalmers ZR; Newberg J; Kim E; Carrot-Zhang J; Piou D; Polak P; Abdulkadir SA; Ziv E; Meyerson M; Frampton GM; Campbell JD; Huang FW
Clin Cancer Res; 2020 Sep; 26(17):4651-4660. PubMed ID: 32651179
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer.
Maddison LA; Huss WJ; Barrios RM; Greenberg NM
Prostate; 2004 Mar; 58(4):335-44. PubMed ID: 14968434
[TBL] [Abstract][Full Text] [Related]
35. Stage at presentation and survival of white and black patients with prostate carcinoma.
Brawn PN; Johnson EH; Kuhl DL; Riggs MW; Speights VO; Johnson CF; Pandya PP; Lind ML; Bell NF
Cancer; 1993 Apr; 71(8):2569-73. PubMed ID: 8453581
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of genomic profile in patients with HER2-positive breast cancer.
Chen B; Zhang G; Wei G; Wang Y; Guo L; Lin J; Li K; Mok H; Cao L; Ren C; Wen L; Jia M; Li C; Hou T; Han-Zhang H; Liu J; Balch CM; Liao N
Endocr Relat Cancer; 2020 Mar; 27(3):153-162. PubMed ID: 31905165
[TBL] [Abstract][Full Text] [Related]
37. CDK12 regulates DNA repair genes by suppressing intronic polyadenylation.
Dubbury SJ; Boutz PL; Sharp PA
Nature; 2018 Dec; 564(7734):141-145. PubMed ID: 30487607
[TBL] [Abstract][Full Text] [Related]
38. Homologous recombination repair gene mutations in Chinese localized and locally advanced prostate cancer patients.
Jiang X; Hu X; Gu Y; Li Y; Jin M; Zhao H; Gao R; Huang Z; Lu J
Pathol Res Pract; 2021 Aug; 224():153507. PubMed ID: 34102435
[TBL] [Abstract][Full Text] [Related]
39. Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.
Ito M; Tanaka T; Toita A; Uchiyama N; Kokubo H; Morishita N; Klein MG; Zou H; Murakami M; Kondo M; Sameshima T; Araki S; Endo S; Kawamoto T; Morin GB; Aparicio SA; Nakanishi A; Maezaki H; Imaeda Y
J Med Chem; 2018 Sep; 61(17):7710-7728. PubMed ID: 30067358
[TBL] [Abstract][Full Text] [Related]
40. Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer.
Antonarakis ES
N Engl J Med; 2018 Sep; 379(11):1087-1089. PubMed ID: 30207914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]